Trial Design
small-vessel cerebral ischemic disease, decline in cognitive function, dementia, cardiovascular disease
SECONDARY, CARDIOVASCULAR DISEASE
The SPRINT trial was designed to examine the effects of intensive SBP control vs standard SBP control on cardiovascular disease as the primary outcome and kidney function, dementia or decline in cognitive function, and small-vessel cerebral ischemic disease as secondary outcomes, as previously described.